These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
599 related articles for article (PubMed ID: 11523408)
1. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)]. Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408 [TBL] [Abstract][Full Text] [Related]
2. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043 [TBL] [Abstract][Full Text] [Related]
3. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310 [TBL] [Abstract][Full Text] [Related]
4. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis. de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of thrombophilia based on coagulation and genetic studies]. Bałszan-Kowalska I Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477 [TBL] [Abstract][Full Text] [Related]
6. Activated protein C resistance--a major risk factor for thrombosis. Rosén SB; Sturk A Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726 [TBL] [Abstract][Full Text] [Related]
7. Resistance to activated protein C in women using oral contraceptives. Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008 [TBL] [Abstract][Full Text] [Related]
8. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978 [TBL] [Abstract][Full Text] [Related]
9. [Clinical findings in individuals with the factor V Leiden mutation]. Matýsková M; Vorlová Z; Hrachovinová I; Buliková A; Zavrelová J; Slechtová M Vnitr Lek; 1997 May; 43(5):298-301. PubMed ID: 9601852 [TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665 [TBL] [Abstract][Full Text] [Related]
12. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Dahlbäck B Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of thrombotic children with malignancy. Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962 [TBL] [Abstract][Full Text] [Related]
15. Acute superior mesenteric vein thrombosis associated with factor V 'Leiden' gene mutation. Shah SR; Gupta AD; Sharma A; Joshi A; Desai D; Abraham P J Assoc Physicians India; 2003 Jun; 51():611-3. PubMed ID: 15266932 [TBL] [Abstract][Full Text] [Related]
16. [Study of the Leiden mutation (factor VQ 506), the most frequent cause of thrombophilia, in 116 thrombosis patients]. Nagy A; Melegh B; Losonczy H Orv Hetil; 1997 Nov; 138(44):2797-800. PubMed ID: 9411348 [TBL] [Abstract][Full Text] [Related]
17. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients. Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861 [TBL] [Abstract][Full Text] [Related]
18. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease. Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251 [TBL] [Abstract][Full Text] [Related]
19. [Thrombophilia caused by congenital disorders of blood coagulation]. Hiller E; Pihusch R Fortschr Med; 1998 Oct; 116(29):26-8, 30, 32 passim. PubMed ID: 9846471 [TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the protein C gene as risk factor for venous thrombosis. Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]